3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Multiple Myeloma
166
Precursor Cell Lymphoblastic Leukemia-Lymphoma
47
Lymphoma
23
Neoplasms, Plasma Cell
21
Leukemia
21
Recurrence
20
Burkitt Lymphoma
18
Lymphoma, Non-Hodgkin
15
Neoplasms
14
Lymphoma, Mantle-Cell
14
Immunoglobulin Light-chain Amyloidosis
14
Nausea
13
Lymphoma, Large B-Cell, Diffuse
13
Vomiting
12
Breast Neoplasms
12
Hodgkin Disease
11
Waldenstrom Macroglobulinemia
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, Follicular
9
Amyloidosis
9
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myeloid, Acute
8
Smoldering Multiple Myeloma
7
Neoplasm Metastasis
7
Leukemia, Biphenotypic, Acute
6
Hematologic Neoplasms
6
Blast Crisis
6
Prostatic Neoplasms
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, B-Cell
5
Interventions
Gemcitabine
8
pembrolizumab
5
Cisplatin
5
enfortumab vedotin
3
avelumab
3
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Carboplatin
3
vinflunine
2
Radiotherapy
2
Nephroureterectomy
2
Immunoglobulin G
2
Doxorubicin
2
Disulfides
2
vandetanib
1
tremelimumab
1
tocilizumab
1
tamibarotene
1
relatlimab
1
pegfilgrastim
1
merphos
1
guadecitabine
1
genexol-PM
1
enzalutamide
1
durvalumab
1
dehydroftorafur
1
atezolizumab
1
abexinostat
1
Vitamin D
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Ureteral Neoplasms
×
Calcium Dobesilate
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled